MedPath

Tyrosine Kinase Inhibitor for the Treatment of Severe Pulmonary Arterial Hypertensio

Not Applicable
Conditions
pulmonary arterial hypertension
Registration Number
JPRN-UMIN000001578
Lead Sponsor
Medical Education Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

patients who can not express subjective symptoms, can not be evaluated through objective improvement, have the decreased number of platelet (less than 30000), have critical anemia (Hb<7.0), have critical liver cirrhosis, are during pregnancy or during lactation, or have critical left heart disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath